510(k) · Cleared
ClearedAutoalign
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Cortechs Labs, Inc. · LLZ System, Image Processing, Radiological
Cleared on Oct 14, 2003 after an 89-day review. The FDA summary names no predicate by number.
- Decided
- Oct 14, 2003
- Review
- 89 days
- Class
- Class II
- Product code
- LLZ
- Recalls
- None
- Predicates
- 0
The FDA summary names no predicate by number.
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LLZ device
- #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against?
The FDA summary names no predicate by number.
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
How does its category compare?
All LLZ devicesLLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · LLZ
58in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LLZ
173in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LLZ
11in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LLZ
116in 2025
MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 76 | 36 | 20 | 152 |
| 2008 | 94 | 52 | 32 | 154 |
| 2009 | 70 | 62 | 21 | 145 |
| 2010 | 51 | 98 | 17 | 145 |
| 2011 | 106 | 79 | 30 | 454 |
| 2012 | 82 | 87 | 12 | 266 |
| 2013 | 95 | 84 | 64 | 1,130 |
| 2014 | 78 | 89 | 6 | 15,631 |
| 2015 | 64 | 90 | 16 | 211 |
| 2016 | 82 | 90 | 12 | 290 |
| 2017 | 78 | 107 | 5 | 104 |
| 2018 | 104 | 105 | 7 | 72 |
| 2019 | 74 | 107 | 2 | 88 |
| 2020 | 81 | 115 | 6 | 82 |
| 2021 | 83 | 116 | 3 | 70 |
| 2022 | 65 | 137 | 4 | 28 |
| 2023 | 87 | 157 | 8 | 26 |
| 2024 | 62 | 131 | 6 | 42 |
| 2025 | 58 | 173 | 11 | 116 |
| 2026 | 45 | 110 | 14 | — |
What is it indicated for?
AutoAlignTM Atlas-Based Image Registration software is intended to provide an output registration matrix that may be utilized to align an MRI brain scan to a known and consistent anatomic orientation, a process known as image registration. AutoAlignTM Atlas-Based Image Registration software is intended to be marketed as a software device that can provide improvements to the manual processes of image registration. The dominant use of AutoAlignTM…
Read the full statement (508 words)
AutoAlignTM Atlas-Based Image Registration software is intended to provide an output registration matrix that may be utilized to align an MRI brain scan to a known and consistent anatomic orientation, a process known as image registration. AutoAlignTM Atlas-Based Image Registration software is intended to be marketed as a software device that can provide improvements to the manual processes of image registration. The dominant use of AutoAlignTM Atlas-Based Image Registration software is its integration into proprietary MR image software packages by MRI scanner manufacturers to allow users to generate consistent patient image registrations for image acquisition, a process otherwise known as Autoslice Prescriptioning.
AutoAlignTM Atlas-Based Image Registration labeling for the device contains instructions for the safe and effective use of this software as demonstrated by testing on 259 acquired image volumes (as detailed below). Labeling may vary in accordance to the proprietary MRI manufacturers systems, but includes the following language:
The accuracy of the auto alignment is affected by the subject‘s deviation from the embedded reference neuroanatomic Atlas. In general, the effectiveness of standardized image registration as measured by the AutoAlignTM Atlas-Based Image Registration software decreases when the subject’s brain includes pathologic features not present in the normal brain, lacks features normally present, or is structurally different than that defined in the pre-existing neuroanatomic Atlas of the normal brain. The accuracy of the AutoAlignTM Atlas-Based Image Registration alignment program can also be degraded by patient motion or by artifacts which are introduced into the patient scanning process. If there is a clinical requirement to characterize a mass lesion or other abnormal pathological feature which differs significantly from the normal brain, the user should not rely upon the AutoAlign feature for image registration and should manually perform image registration. To assure adequate registration is achieved, the software calculates a Measurement Index (MI) which reflects the adequacy of alignment. If the Measurement Index exceeds specified anatomic limits, user intervention is required.
Factors which degrade the technical quality of MR images or pathologic processes which significantly affect neuroanatomic structure may decrease the alignment accuracy of the Autoalign software. Such factors include:
a. Patient’s motion during scan.
c. Artifacts affecting overall image quality.
d. Brains showing gross amount of structural abnormality.
e. Resections must not be larger than 30 cc.
f. Tumors must not be larger than 15 cc.
AutoAlign demonstrates the following registration capabilities for MRI Neuro exams subject to the limitations set forth above and in product operating labeling documents:
The inter-subject variability of the position of the anterior commissure (AC) is less than 15 mm.
The inter-subject variability of the position of the posterior commissure (PC) is less than 13 mm.
The inter-subject variability of the positioning of the inter-hemispheric plane (as measured on sagittal views) is less than 6 mm.
The inter-subject variability of the angle formed by the inter-hemispheric plane and the anterior-posterior line (as measured on axial views) is less than 5.
The inter-subject variability of the angle formed by the inter-hemispheric plane and the superior-inferior line (as measured on coronal views) is less than 7 degrees.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K032186 · printed Nov 6, 2026
Cite this page
510(k) Report. “K032186: Autoalign.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032186
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Page last updated Nov 3, 2026